Increased levels of a subset of angiogenesis-related plasma proteins in essential thrombocythemia

Background Increased local angiogenesis is important for the growth and dissemination of cancer. The myeloproliferative neoplasm essential thrombocythemia (ET) is known to involve increased bone marrow angiogenesis. Blood levels of several angiogenesis-related proteins are increased in different types of cancer. The aim of this study was to investigate whether a subset of such proteins was elevated in treatment-naïve ET patients. Methods Blood plasma from 41 ET patients and 43 healthy aged-matched controls was analyzed for eight different angiogenesis-related proteins. Results The ET cohort displayed a more homogenous expression pattern of these proteins compared with controls. Five of the eight proteins were significantly increased in ET patients. Conclusion Increased plasma levels of matrix metallopeptidase 9 (MMP9) and endostatin have not previously been reported in ET. In our patients, MMP9 levels correlated positively with Janus kinase 2 (JAK2) V617F allele burden and leukocyte count.

[1]  C. Gieger,et al.  Neutrophil “plucking” on megakaryocytes drives platelet production and boosts cardiovascular disease , 2022, Immunity.

[2]  M. Höglund,et al.  PLASMA PROTEIN BIOMARKER PROFILING REVEALS MAJOR DIFFERENCES BETWEEN ACUTE LEUKAEMIA, LYMPHOMA PATIENTS AND CONTROLS. , 2022, New biotechnology.

[3]  Hae-June Lee,et al.  Ionizing Radiation-Induced GDF15 Promotes Angiogenesis in Human Glioblastoma Models by Promoting VEGFA Expression Through p-MAPK1/SP1 Signaling , 2022, Frontiers in Oncology.

[4]  R. Amini,et al.  Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue , 2021, Cancers.

[5]  A. Cattaneo,et al.  Pentraxin 3 Inhibits the Angiogenic Potential of Multiple Myeloma Cells , 2021, Cancers.

[6]  J. Koča,et al.  Selectins—The Two Dr. Jekyll and Mr. Hyde Faces of Adhesion Molecules—A Review , 2020, Molecules.

[7]  I. Sagi,et al.  Emerging roles of ECM remodeling processes in cancer. , 2020, Seminars in cancer biology.

[8]  M. E. Alvarez-Sánchez,et al.  Role of Matrix Metalloproteinases in Angiogenesis and Cancer , 2019, Front. Oncol..

[9]  G. Uzan,et al.  GDF15 secreted by senescent endothelial cells improves vascular progenitor cell functions , 2019, PloS one.

[10]  S. Oltean,et al.  Alternative Splicing in Angiogenesis , 2019, International journal of molecular sciences.

[11]  N. Ferrara,et al.  VEGF in Signaling and Disease: Beyond Discovery and Development , 2019, Cell.

[12]  O. Haus,et al.  Selected Parameters of Angiogenesis and the JAK2, CALR, and MPL Mutations in Patients With Essential Thrombocythemia , 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[13]  A. Bishayee,et al.  Matrix Metalloproteinases: A challenging paradigm of cancer management. , 2017, Seminars in cancer biology.

[14]  D. Azar,et al.  Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications. , 2015, Biochimica et biophysica acta.

[15]  C. Garlanda,et al.  Pentraxin 3 mediates neurogenesis and angiogenesis after cerebral ischaemia , 2015, Journal of Neuroinflammation.

[16]  J. Quigley,et al.  Tissue-Infiltrating Neutrophils Constitute the Major In Vivo Source of Angiogenesis-Inducing MMP-9 in the Tumor Microenvironment12 , 2014, Neoplasia.

[17]  S. Stacker,et al.  Lymphangiogenesis and lymphatic vessel remodelling in cancer , 2014, Nature Reviews Cancer.

[18]  M. Çalan,et al.  The levels of adhesion molecules in essential thrombocythemia. , 2013, Panminerva Medica (Testo stampato).

[19]  E. B. Ateşoğlu,et al.  Serum hepcidin and growth differentiation factor‐15 (GDF‐15) levels in polycythemia vera and essential thrombocythemia , 2013, European journal of haematology.

[20]  B. Klein,et al.  Bioactivity and prognostic significance of growth differentiation factor GDF15 secreted by bone marrow mesenchymal stem cells in multiple myeloma. , 2012, Cancer research.

[21]  P. Pioltelli,et al.  Circulating endothelial cells and endothelial activation in essential thrombocythemia: Results from CD146+ immunomagnetic enrichment—flow cytometry and soluble E‐selectin detection , 2012, American journal of hematology.

[22]  P. Smolewski,et al.  Circulating endothelial cells in essential thrombocythemia and polycythemia vera: correlation with JAK2-V617F mutational status, angiogenic factors and coagulation activation markers , 2010, International journal of hematology.

[23]  T. Barbui,et al.  Nitric oxide derivatives and soluble plasma selectins in patients with myeloproliferative neoplasms , 2010, Thrombosis and Haemostasis.

[24]  John C Chappell,et al.  Local guidance of emerging vessel sprouts requires soluble Flt-1. , 2009, Developmental cell.

[25]  C. Dabrosin,et al.  Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo. , 2008, Cancer research.

[26]  T. Matsuishi,et al.  Ischemia‐induced angiogenesis: role of inflammatory response mediated by P‐selectin , 2006, Journal of leukocyte biology.

[27]  J. Martin Collinson,et al.  Corneal avascularity is due to soluble VEGF receptor-1 , 2006, Nature.

[28]  N. Agnantis,et al.  Clinical Correlation of Bone Marrow Microvessel Density in Essential Thrombocythemia , 2005, Acta Haematologica.

[29]  T. Salo,et al.  Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases. , 2005, Experimental cell research.

[30]  A L Zhou,et al.  Matrix metalloproteinase activity is required for activity-induced angiogenesis in rat skeletal muscle. , 2000, American journal of physiology. Heart and circulatory physiology.

[31]  I. Weissman,et al.  A clonogenic common myeloid progenitor that gives rise to all myeloid lineages , 2000, Nature.

[32]  S. Rafii,et al.  Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. , 2000, Blood.

[33]  A. Evans,et al.  Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. , 1999, Circulation.

[34]  Gabriele Bergers,et al.  MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes , 1998, Cell.

[35]  A. Koch,et al.  Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1 , 1995, Nature.

[36]  Ying Su,et al.  Genetic polymorphism c.1562C>T of the MMP-9 is associated with macroangiopathy in type 2 diabetes mellitus. , 2010, Biochemical and biophysical research communications.

[37]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[38]  A. Green,et al.  Essential thrombocythemia. , 2003, Hematology/oncology clinics of North America.